Product NDC: | 42023-167 |
Proprietary Name: | Zoledronic Acid |
Non Proprietary Name: | Zoledronic Acid |
Active Ingredient(s): | 4 mg/5mL & nbsp; Zoledronic Acid |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION, CONCENTRATE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 42023-167 |
Labeler Name: | JHP Pharmaceuticals, LLC. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA202571 |
Marketing Category: | ANDA |
Start Marketing Date: | 20130507 |
Package NDC: | 42023-167-01 |
Package Description: | 1 VIAL, GLASS in 1 CARTON (42023-167-01) > 5 mL in 1 VIAL, GLASS |
NDC Code | 42023-167-01 |
Proprietary Name | Zoledronic Acid |
Package Description | 1 VIAL, GLASS in 1 CARTON (42023-167-01) > 5 mL in 1 VIAL, GLASS |
Product NDC | 42023-167 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Zoledronic Acid |
Dosage Form Name | INJECTION, SOLUTION, CONCENTRATE |
Route Name | INTRAVENOUS |
Start Marketing Date | 20130507 |
Marketing Category Name | ANDA |
Labeler Name | JHP Pharmaceuticals, LLC. |
Substance Name | ZOLEDRONIC ACID |
Strength Number | 4 |
Strength Unit | mg/5mL |
Pharmaceutical Classes | Bisphosphonate [EPC],Diphosphonates [Chemical/Ingredient] |